Abstract:Objective To evaluate clinical features,insulin sensitivity,and serum adipocytokines levels in pregnant women with different glucose tolerance status and to investigate the possible serum predictive biomarkers of gestational diabetes mellitus (GDM).Methods We included 74 pregnant women with positive results of 50 g glucose challenge test (GCT),who received regular obstetrical follow-up in Peking Union Medical College Hospital from January 2009 to June 2012.A further 100 g oral glucose tolerance test was performed in 24-28 gestational weeks,based on which the 74 pregnant women were divided into GDM group (n =25),impaired glucose tolerance (IGT) group (n =25) and normal glucose tolerance (NGT) group (n =24).The clinical data were recorded in detail.Serum fibroblast growth factor (FGF)-19,FGF-21,visceral adiposespecific serine protease inhibitor (vaspin),leptin,insulin-like growth factor binding protein-1 (IGFBP-1),and adiponectin levels of the 3 groups were measured by enzyme-linked immunosorbent assay (ELISA) and compared.The associations of these adipocytokines with the patients' baseline data and metabolic indexes were analyzed.Results The blood glucose after GCT and glycosylated hemoglobin A1c in the GDM group were significantly higher than those in the NGT group [(9.21 ±0.75) mmol/L vs.(8.52 ±0.50) mmol/L,P ＜0.05;(5.39 ± 0.34) ％ vs.(5.18 ± 0.20) ％,P ＜ 0.05],but not significantly different from those in the IGT group [(9.14 ± 0.64) mmol/L,P ＞ 0.05;(5.28 ± 0.28) ％,P ＞ 0.05].Age,systolic blood pressure and diastolic blood pressure in the first trimester,pre-gestational body mass index (BMI),increment of BMI during pregnancy,serum total cholesterol,triglyceride,high-density lipoprotein cholesterol,low-density lipoprotein cholesterol,and C-reactive protein levels in the three groups showed no significant differences (all P ＞0.05).From the NGT group to the IGT group to the GDM group,the area under curve of blood glucose (AUCBG) [(19.84±1.95),(23.20±1.51),(26.58±2.02) mmol/(L · h)] and AUC of insulin (AUCINS) [(1.84± 0.91) ×103,(1.85 ±1.15) ×103,(2.49 ±1.36) ×103 pmol/(L · h)] both gradually increased.Compared with the NGT group,the GDM group had significantly higher HOMA-IR [3.0 (1.5,5.2) vs.2.5 (1.5,3.4),P ＜0.05] significantly lower HOMA-β [230.5 (144.6,311.6) vs.235.6 (168.1,350.0),P ＜ 0.05].Among the GDM,the IGT,and the NGT groups,there were no significant differences in serum FGF-19 [(284.42±78.16),(268.17 ±72.97),(283.86 ±79.74) ng/L],FGF-21 [(798.16±273.57),(882.43 ±322.17),(842.75 ±343.01) ng/L],vaspin [(22.36 ±7.27),(23.53 ±7.90),(22.63±9.11) μag/L],leptin [(5.51 ± 1.44),(5.58 ± 1.58),(5.48 ± 1.47) μg/L],adiponectin [(798.85 ± 255.14),(863.44 ± 252.18),(828.36 ± 249.32) μg/L] and IGFBP-1 [(40.44 ± 16.41),(49.57±12.60),(43.80±16.58) μg/L] levels (all P＞0.05).Conclusions There are no significant differences of a variety of adipocytokines in pregnant women with different glucose tolerance status,and no effective serum predictors of GDM are found.The effect of adipocytokines in the pathogenesis of GDM remains to be further investigated.

Clinical Analysis of the Relationship Between Blood Lipids of Pregnancy and Gestational Diabetes Mellitus and Macrosomia

Associations between maternal lipid profile and pregnancy complications and perinatal outcomes: a population-based study from China

The Small Dense LDL Particle/large Buoyant LDL Particle Ratio is Associated with Glucose Metabolic Status in Pregnancy

Impact of Pre-Pregnancy Body Mass Index, Weight Gain and Blood Lipid Level During Pregnancy on Pregnancy Outcome in Patients with Gestational Diabetes Mellitus.

Serum adipocytokines in pregnant women with different glucose metabolism status

The Association of Gestational Diabetes Mellitus with Fetal Birth Weight.

Pre-pregnancy LDL/HDL and Total Cholesterol/HDL Ratios Are Strong Predictors of Gestational Diabetes Mellitus in Women Undergoing Assisted Reproductive Technologies

Relationship of Abnormal Mid-Term Oral Glucose Tolerance Test and Maternal Weight Gain with Adverse Pregnancy Outcomes in Women with Gestational Diabetes Mellitus

Association of lipid levels at different stages of pregnancy with gestational diabetes mellitus and the incidence of neonatal macrosomia: A retrospective study

Relationship Between Blood Lipid Levels of Pregnant Women with Glucose Metabolism Disorders and Perinatal Outcomes

Association between lipid trajectories during pregnancy and risk of postpartum glucose intolerance after gestational diabetes mellitus: a cohort study

Serum lipid levels in relation to clinical outcomes in pregnant women with gestational diabetes mellitus: an observational cohort study

Association between maternal lipid profiles and lipid ratios in early to middle pregnancy as well as their dynamic changes and gestational diabetes mellitus

Associations of lipid levels during gestation with hypertensive disorders of pregnancy and gestational diabetes mellitus: a prospective longitudinal cohort study.

Blood lipids levels and perinatal outcome of the patients with gestational diabetes mellitus at late phase

Relationship Between Maternal Serum Lipid Levels and Newborn Weight in Pregnant Women with Single Positive Diabetic Screening Test

Relationship between lipid metabolism and pregnant outcomes in women with abnormal gestational glucose metabolism

Blood-lipid profile of pregnant women with gestational diabetes or impaired glucose tolerance during late pregnancy and its relation with maternal body weight

Maternal Serum Lipid and Uric Acid Levels at 20 Weeks of Gestation in Predicting Preeclampsia, Gestational Diabetes Mellitus and Macrosomia

The influence of lipids on adverse pregnancy outcomes differs between normal glucose tolerance and gestational diabetes mellitus women: a retrospective study

Association of Insulin Resistance and Β-Cell Function with Macrosomia among Pregnant Women with Gestational Diabetes Mellitus